Chromogenex launches non-surgical fat reduction and body shaping system

Apr 7 2014

Chromogenex, a world leader in laser innovation, announced today the launch of i-LipoXcell, the company's non-surgical fat reduction and body shaping system. Representing third generation technology, i-LipoXcell incorporates both visible red and infrared lasers for bio-stimulation of metabolic pathways, effectively shrinking fat cells through the release of fatty acids and glycerol. The i-LipoXcell laser system is clinically proven to provide effective results immediately after as few as one treatment, with an average of one inch per 20-minute treatment.

"i-LipoXcell is extremely gentle on the body and swiftly eliminates excess fat with remarkable instant results," said Pete McGuinness, Chief Executive Officer of Chromogenex. "This unique combination of laser technology is a huge breakthrough in aesthetics, and we see i-LipoXcell as being very unique to the marketplace."

i-LipoXcell incorporates three technologies for intelligent body fat analysis and measurement, laser diode fat reduction and IR Vacuum massage. i-LipoXcell is clinically proven for safety and treatment is comfortable, backed by leading physicians in worldwide multi-center studies. Results are seen immediately.  Treatment can target specific stubborn pockets of fat, as well as reshaping the body.

i-LipoXcell is FDA cleared for circumferential reduction and improvement in the appearance of cellulite. Laser treatment is followed by combination laser/massage to enhance lymphatic drainage, improve circulation and achieve deeper penetration of laser into fat cells.

Renowned dermatologist Steven D. Shapiro, M.D. of Gardens Dermatology, Palm Beach Gardens, FL had this to say about i-LipoXcell: "I have been in practice for 20 years and have seen many different new technologies. i-LipoXcell has been a "wow" in terms of results with no risk and high benefit." Beverly Hills, CA plastic surgeon Jon A. Perlman, M.D. added:"i-LipoXcell is innovative, painless and very effective."